We interviewed Tania Dempsey MD about Mast Cell Activation Syndrome (MCAS). In this webinar, Dr. Dempsey answered the following questions:
- What is Mast Cell Activation Syndrome?
- What are its symptoms?
- What are common triggers of MCAS?
- What is the link between MCAS and infections such as Lyme disease, Bartonella, PANS and PANDAS?
- How having MCAS means that children with eczema, allergies and asthma are more likely to develop autism, ADHD and SPD?
Please note that you will be asked to enter your email address at the 30-minute mark to finish viewing the video.
About Tania Dempsey MD
Tania Dempsey, MD, ABIHM is a board-certified internist and diplomate of the American Board of Integrative Holistic Medicine. She received her MD degree from The Johns Hopkins University School of Medicine and her BS degree from Cornell University. She completed her Internal Medicine Residency at New York University.
In 2011, she founded Armonk Integrative Medicine (AIM) which has become a destination practice in Purchase, NY, focusing on complex, multi-system diseases. Dr. Dempsey is an expert in tick-borne infections, Mast Cell Activation Syndrome and autoimmunity.
She is an accomplished international speaker and writer and was the Keynote Speaker in 2018 at the International Congress on Natural Medicine in Melbourne, Australia. She has been featured on Fox 5 NY News, Observer, Reader’s Digest, Harper’s Bazaar, Huffington Post, Clean Plates, Prevention, SHAPE Magazine, The NY Post and countless other media outlets.
For more information, visit www.drtaniadempsey.com
This webinar is not a substitute for medical advice, treatment, diagnosis, or consultation with a medical professional. It is intended for general informational purposes only and should not be relied on to make determinations related to treatment of a medical condition. Epidemic Answers has not verified and does not guaranty the accuracy of the information provided in this webinar.
Sources & References
Afrin, L.B., et al. Often seen, rarely recognized: mast cell activation disease–a guide to diagnosis and therapeutic options. Ann Med. 2016;48(3):190–201. doi:10.3109/07853890.2016.1161231.
Afrin, L.B., et al. Mast cell activation disease: An underappreciated cause of neurologic and psychiatric symptoms and diseases. Brain Behav Immun. 2015;50:314–321. doi:10.1016/j.bbi.2015.07.002.
Campbell, et al. Mechanisms of Allergic Disease – Environmental and genetic determinants for the development of allergy. Clin Exp Allergy. 2015
Della Giustina, A., et al.. Vitamin D, allergies and asthma: focus on pediatric patients. World Allergy Organ J. 2014;7(1):27
Feehley, T., et al. Healthy infants harbor intestinal bacteria that protect against food allergy. Nature Medicine. 2019 Jan 14.
Frieri, M. Mast Cell Activation Syndrome. Clin Rev Allergy Immunol. 2018;54(3):353–365. doi:10.1007/s12016-015-8487-6.
Frieri, M., et al. Mast cell activation syndrome: a review. Curr Allergy Asthma Rep. 2013;13(1):27–32. doi:10.1007/s11882-012-0322-z.
Gupta, R.S., et al. The Public Health Impact of Parent-Reported Childhood Food Allergies in the United States. Pediatrics. 2018 Dec;142(6). pii: e20181235.
Hamilton, M.J. Nonclonal Mast Cell Activation Syndrome: A Growing Body of Evidence. Immunol Allergy Clin North Am. 2018;38(3):469–481. doi:10.1016/j.iac.2018.04.002.
Ly, N.P., et al. Gut microbiota, probiotics, and vitamin D: interrelated exposures influencing allergy, asthma, and obesity? J Allergy Clin Immunol. 2011;127(5):1087-94; quiz 95-6
Maksimova, O.V., et al. [Intestine microbiota and allergic diseases]. Zh Mikrobiol Epidemiol Immunobiol. 2014(3):49-60.
Petra, A.I., et al. Spectrum of mast cell activation disorders. Expert Rev Clin Immunol. 2014;10(6):729–739. doi:10.1586/1744666X.2014.906302
Prescott, S.L. Early-life environmental determinants of allergic diseases and the wider pandemic of inflammatory noncommunicable diseases. J Allergy Clin Immunol. 2013;131(1):23-30
Theoharides, T.C., et al. Neuro-inflammation, blood-brain barrier, seizures and autism. J Neuroinflammation 8, 168 (2011) doi:10.1186/1742-2094-8-168.
Tsabouri, S., et al. Modulation of gut microbiota downregulates the development of food allergy in infancy. Allergol Immunopathol (Madr). 2014;42(1):69-77.